Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Clin Transplant. 2020 Apr 25;34(6):e13827. doi: 10.1111/ctr.13827

TABLE 4.

Summary of SNPs-by-APOL1 interactions with full model meta-analysis P-values ≤ 7.5 × 10−7

Discovery (Wake Forest, UAB, Emory) Validation (DeKAF Genomics) Meta-Analysis



SNP Chromosome Position Nearest Gene Alleles MAF Estimate SE P-value Estimate SE P-value Estimate P-value Sign I2
rsl695847 1 1431806 ATAD3B A/C 0.09 −3.99 0.80 6.4 × 10−7 −1.34 3.90 0.73 −3.88 7.2 × 10−7 0.00
rs76455983 2 53 105 036 G/T 0.09 1.44 0.28 2.8 × 10−7 2.21 0.96 0.02 1.50 2.5 × 10−8 ++ 0.00
rs7582966 2 104 018 063 C/T 0.49 −1.27 0.24 1.6 × 10−7 0.13 0.88 0.89 −1.17 5.4 × 10−7 −+ 0.57
rs6906957 6 108 206 385 SEC63 A/G 0.23 1.58 0.26 2.0 × 10−9 0.87 0.64 0.18 1.48 1.3 × 10−9 ++ 0.03
rs73710129 8 129 073 950 PVT1 T/C 0.12 1.46 0.27 4.1 × 10−8 −0.15 0.64 0.82 1.22 6.5 × 10−7 +− 0.81
rs4889062 16 80 018 950 A/G 0.29 1.41 0.27 1.3 × 10−7 0.43 0.86 0.62 1.32 2.1 × 10−7 ++ 0.15

Note: Estimate, Coefficient estimate associated with the SNP-by-APOLl interaction term in the model; SE, standard error; DE, direction of effect; I2, A measure of heterogeneity between studies; Adjustment, individual admixture proportion, ages of the donor and the recipient, sex, recipient race, transplant center, HLA match, cold ischemia time, panel reactive antibodies, donor age, and donor type (standard donor vs extended-criteria donor).